Holen Sie sich die Stockscreener-App
198.65
1.22%
2.39
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$196.26
Offen:
$196.595
24-Stunden-Volumen:
1.13M
Relative Volume:
1.17
Marktkapitalisierung:
$12.75B
Einnahmen:
$13.64B
Nettoeinkommen (Verlust:
$1.05B
KGV:
20.79
EPS:
9.555
Netto-Cashflow:
$1.31B
1W Leistung:
+30.99%
1M Leistung:
+33.83%
6M Leistung:
+60.60%
1J Leistung:
+38.31%
1-Tages-Spanne:
$193.85
$199.27
1-Wochen-Bereich:
$148.00
$199.27
52-Wochen-Spanne:
$101.00
$199.27
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
198.65 | 12.75B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
435.19 | 96.54B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
190.38 | 16.40B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.03 | 11.83B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
106.10 | 10.53B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita Inc. stock (US23918K1088): Q1 2026 earnings and share buybacks lift sentiment - AD HOC NEWS
Insider Sell: James Hearty Sells Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Surging Earnings Estimates Signal Upside for DaVita HealthCare (DVA) Stock - Yahoo Finance
DaVita Inc stock (US23804L1035): Shares surge after Q1 beat and guidance hike - AD HOC NEWS
DaVita Inc. Stock (US23918K1088): Analyst Upgrade and Earnings Outlook Drive Investor Interest - AD HOC NEWS
DaVita (DVA) Sees 19.6% Surge, Reaches $187.75 - GuruFocus
DaVita (DVA) Revenue Growth Drives Deutsche Bank Upgrade to Buy Rating - Insider Monkey
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita (DVA) Is Up 27.6% After Boosting 2026 EPS Guidance On Strong Q1 Results - Yahoo Finance UK
UBS Adjusts Price Target on DaVita to $235 From $190, Maintains Buy Rating - marketscreener.com
DaVita: Improved Volumes And Tech In Focus (Rating Upgrade) (NYSE:DVA) - Seeking Alpha
Barclays Adjusts Price Target on DaVita to $194 From $158 - marketscreener.com
DaVita Inc. (NYSE:DVA) Q1 2026 Earnings Call Transcript - Insider Monkey
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
DaVita Inc. Lifts Guidance After Earnings Beat - TipRanks
AMD Soars on AI Boom, Uber Climbs, DaVita Surges - StartupHub.ai
BofA raises DaVita stock price target to $145 on Q1 beat - Investing.com UK
DaVita CFO and VP to join investor chat at BofA Health Care Conference on May 12, 2026 - Pluang
DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference - ChartMill
Research Alert: CFRA Maintains Buy Rating On Shares Of Davita Inc. - 富途牛牛
DaVita raises annual guidance on robust dialysis demand - marketscreener.com
DaVita (DVA) Stock Jumps As Earnings Smash Expectations - timothysykes.com
DaVita (DVA) Stock Surges After Blowout Q1 Earnings Beat - StocksToTrade
DaVita (DVA) Stock Jumps After Big Earnings Beat And Guidance Hike - timothysykes.com
DaVita stock jumps after Q1 beat, guidance hike (DVA:NYSE) - Seeking Alpha
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today - Benzinga
DVA Q1 Deep Dive: Operational Discipline and Technology Investments Drive Outperformance - StockStory
Davita Healthcare stock hits 52-week high at $171.50 - Investing.com
DaVita Stock Jumps As Earnings Beat Fuels Bullish Outlook - StocksToTrade
DaVita Stock Up Following Q1 Earnings & Revenue Beat, Margins Expand - Yahoo Finance
This AMD Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
DaVita (DVA) Jumps After Powerful Q1 Earnings Beat - timothysykes.com
DaVita shares jump as Q1 results beat expectations and full-year outlook rises - Quiver Quantitative
DaVita jumps 20% after Q1 beat, raises outlook - Breakingthenews.net
Why is DaVita HealthCare Partners stock surging today? By Investing.com - Investing.com Canada
Why is DaVita HealthCare Partners stock surging today? - Investing.com
Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday - Benzinga
DaVita Stock Soars 18%+: Dialysis Giant Crushes Q1 Earnings, Raises 2026 Outlook on Strong Demand - International Business Times Australia
DaVita Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Deutsche Bank Upgrades DaVita to Buy From Hold, Raises Price Target to $220 From $126 - marketscreener.com
DVA | DaVita Inc. FinancialsIncome Statement - Quiver Quantitative
BofA raises DaVita stock price target to $145 on Q1 beat By Investing.com - Investing.com South Africa
DaVita Continues to Outperform Key Peer Fresenius Medical Care - Morningstar
DaVita Q1 Earnings Call Highlights - Yahoo Finance
Deutsche Bank upgrades DaVita stock rating on revenue beat - Investing.com
Deutsche Bank upgrades DaVita stock rating on revenue beat By Investing.com - Investing.com Canada
Is DaVita’s Q1 2026 Margin Upside Quietly Recasting The Cost Efficiency Story For DVA? - simplywall.st
DaVita (DVA) Q1 2026 Earnings Call Transcript - Fortune
DaVita Inc. Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
Berkshire Hathaway has sold 1.2 million shares of DaVita at $149.8429 per sharefiling - marketscreener.com
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):